FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology. What is presented is using secoisolariciresinol as a haemorheological, anti-platelet and endothelium-protective agent.
EFFECT: 11-30% lower blood viscosity, 15% lower ADP-induced platelet aggregation, 65% lower endothelial dysfunction coefficient as compared to the reference under the action of secoisolariciresinol have been shown.
3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
AGENT SHOWING ENDOTHELIUM-PROTECTIVE ACTIVITY | 2011 |
|
RU2455018C1 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
HEMORHEOLOGICAL AND ANTI-THROMBOSIS AGENT | 2003 |
|
RU2242221C1 |
HEMORHEOLOGICAL AND ANTITHROMBOTIC AGENT | 2003 |
|
RU2239423C1 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
AGENT POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2696583C1 |
METHOD OF CORRECTION OF EXPERIMENTAL GESTATIONAL TOXICOSIS BY TAURINE ADMINISTRATION | 2017 |
|
RU2672475C2 |
Authors
Dates
2014-11-10—Published
2013-07-26—Filed